Goldrich Research Registry

What is the Purpose of this Study?

The purpose of this study is to create a registry of participants who are interested in participating in future research related to Alzheimer's Disease and other memory disorders. The registry will facilitate identification of subjects for research studies as their information will be readily available for contact. • The primary research procedure is completion of a questionnaire to indicate interest and provide contact information for the potential subject and their study partner as well as review and collection of medical records.


Eligibility

People ages ≥ 18 and older

Competent to give informed consent or have a legally authorized representative to provide informed consent

This study enrolls healthy people, and people with signs and symptoms of cognitive decline and/or neurodegenerative disease (e.g. Alzheimer's disease, Dementia with Lewy bodies, Parkinson's disease, Progressive Supranuclear Palsy, Corticobasal degeneration, Frontotemporal Dementia, Primary Progressive Aphasia, ALS).


Where can I participate?

Cedars Sinai Medical Center

More about this Clinical Trial

What is the full name of this clinical trial?

Jona Goldrich Research Registry

Study Details
Disease Type/Condition

Normal Cognition, Mild cognitive impairment (MCI), Alzheimer's disease, Dementia with Lewy Bodies (DLB), Frontotemporal dementia (FTD), Primary Progressive Aphasia (PPA), Progressive supranuclear palsy (PSP), Corticobasal degeneration (CBD), Amyotrophic lateral sclerosis (ALS), Parkinson's Disease, Memory Disorders

Principal Investigator

Kremen, Sarah

Co-Investigators

Mitzi Gonzales, Zaldy Tan

Age Group

Adult

Phase

Any Phase

IRB Number

STUDY00001472

ClinicalTrials.gov ID

Not Available

Key Eligibility
ClinicalTrials.gov

How do I learn more about this study?
Name

Demarko Flanagan

Phone
(424) 315-0809
Email
demarko.flanagan@cshs.org
Study Detail
Disease Type/Condition

Normal Cognition, Mild cognitive impairment (MCI), Alzheimer's disease, Dementia with Lewy Bodies (DLB), Frontotemporal dementia (FTD), Primary Progressive Aphasia (PPA), Progressive supranuclear palsy (PSP), Corticobasal degeneration (CBD), Amyotrophic lateral sclerosis (ALS), Parkinson's Disease, Memory Disorders

Principal Investigator

Kremen, Sarah

Age Group

Adult

Phase

Any Phase

IRB Number

14-STUDY00001472

ClinicalTrials.gov ID

Not Available

Key Eligibility
ClinicalTrials.gov

Contact
Name

Demarko Flanagan

Phone
(424) 315-0809
Email
demarko.flanagan@cshs.org